Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Vertex Pharmaceuticals 3.334, Baxter International 2.96.
Vertex Pharmaceuticals vs Baxter International: Revenue Comparison
Vertex Pharmaceuticals (VRTX) and Baxter International (BAX) are peers in Healthcare. Vertex Pharmaceuticals reported revenue of $3.3B as of Q2 2026, compared with $3.0B for Baxter International. Vertex Pharmaceuticals leads on revenue.
Vertex Pharmaceuticals's gross margin is 85.3% versus 34.9% for Baxter International. Vertex Pharmaceuticals's net margin is 33.0% versus 4.3% for Baxter International.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Vertex Pharmaceuticals, Baxter International.| Metric | Vertex Pharmaceuticals | Baxter International |
|---|---|---|
| Market Cap | - | - |
| Revenue | $3.33B | $2.96B |
| Cost of Revenue | $489.00M | $1.93B |
| Gross Profit | $2.85B | $1.03B |
| Operating Income | $1.25B | $217.00M |
| Net Income | $1.10B | $126.00M |
| R&D Expense | $994.00M | $129.00M |
| Earnings Per Share | $4.31 | $0.24 |
| Gross Margin | 85.3% | 34.9% |
| Operating Margin | 37.4% | 7.3% |
| Net Profit Margin | 33.0% | 4.3% |
| Free Cash Flow | $1.01B | $32.00M |
| Cumulative Free Cash Flow | $17.24B | $35.82B |
| Operating Cash Flow | $1.13B | $285.00M |
| Cash & Equivalents | $6.14B | $2.15B |